Affimed shares slide as biotech to end cancer program, focus on innate immunity
Clinical stage biotech Affimed N.V. AFMD, -0.60% said Wednesday it is terminating its phase I program for AFM11 to focus on its innate immunity portfolio. The company had put two clinical trials of the cancer treatment on hold back in October after one patient died and two others experienced life-threatening events in the high-dose group. The trials were testing the drug in patients with types of non-Hodgkin lymphoma and acute lymphoblastic leukemia.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Former Bush official puts Trump on the couch: a ‘10 out of 10 narcissist’Larry Lindsey told House Republican leaders he had two psychologists evaluate Trump from afar.
Read more »
10 Things to Know for TodayAmong 10ThingstoKnow: Dual hearings on Capitol Hill focus on Trump's Iran policy; McGahn to skip hearing as Democrats debate next steps; 'Medicare for All's' benefits 'leapfrog' other nations.
Read more »
2019 Disruptor 50: No. 10 XiaohongshuChinese start-up Xiaohongshu — which translates to 'little red book' — has become China's leading social e-commerce platform for overseas luxury goods, primarily fashion and beauty products. Disruptor50
Read more »
Ford Motor Co to cut 10% of white-collar jobs as part of global restructuringFord Motor Co said on Monday it will eliminate about 10% of its global salaried ...
Read more »
10 Photo Stories That Will Challenge Your View Of The WorldHere are some of the most interesting and powerful photo stories from across the internet.
Read more »
Johnson & Johnson to submit applications for at least 10 new drugs by 2023Johnson & Johnson said on Wednesday it expected to file marketing applications f...
Read more »
Here's how much a $1,000 investment in Walmart 10 years ago would be worth nowHere's how much a $1,000 investment in Walmart 10 years ago would be worth now (via CNBCMakeIt)
Read more »
10 Small Business Apps, Services And Tech Platforms Every Entrepreneur Should Know AboutThere are a few apps, services and technologies – about ten categories in all – that are critical for small businesses in 2019. Here they are.
Read more »